PIK3CA and neoplasm: In recent years, the major oncogenic pathways have been elucidated that drive tumor initiation and progression in NMTC, which mainly comprise the RAS-RAF-MEK-ERK and PI3K-AKT-mTOR signaling pathways (6, 35).